Disclosure statement
AD has received personal consultancy fees from InCycle, EUSA and Loxo, and has received research support from Roche and Takeda. MR participates in a scientific advisory board for and has equity in Auron Therapeutics, Inc., has received research support from Roshe, NGM and Beat AML. MY has received personal consultancy fee from Janssen Research and Development. The remaining authors declare no financial interests. No potential conflict of interest was reported by the author(s).